Cargando…
60 Presence and Degree of Neutralizing Antibody Production Following Pfizer-BioNTech Vaccination
Autores principales: | Pepe, P.E., Antevy, P.M., Marty, A.M., Jui, J., Cabral, M., Rosenberg, L., Scheppke, K.A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8335500/ http://dx.doi.org/10.1016/j.annemergmed.2021.07.062 |
Ejemplares similares
-
23 Degree, Timing and Factors Observed in COVID-19 Post-Vaccination Humoral Antibody Development
por: Pepe, P.E., et al.
Publicado: (2021) -
MRI Negative Myelitis Induced by Pfizer-BioNTech COVID-19 Vaccine
por: Cabral, Gonçalo, et al.
Publicado: (2022) -
Myocarditis with Pfizer-BioNTech's COVID-19 vaccine in Israel
Publicado: (2021) -
Thrombocytopenia with Pfizer-BioNTech or Moderna COVID-19 vaccines
Publicado: (2021) -
Pfizer-BioNTech COVID-19 vaccine safe in children
Publicado: (2022)